{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:23:43Z","timestamp":1785018223980,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.critrevonc.2025.104782","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:48:14Z","timestamp":1748774894000},"page":"104782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Impact of the tumor microenvironment on progression and treatment response in lymphoma and chronic lymphocytic leukemia: A systematic review of the literature"],"prefix":"10.1016","volume":"213","author":[{"given":"Sebastian Villamizar","family":"Castellanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paula Rodriguez","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Camila Gil","family":"Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Cielo Arias","family":"Asprilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Santiago Garcia","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3324\/haematol.2019.243626","article-title":"Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma","volume":"106","author":"Autio","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2025.104782_bib2","article-title":"Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis","volume":"2019","author":"Cioroianu","year":"2019","journal-title":"Anal. Cell Pathol. Amst."},{"key":"10.1016\/j.critrevonc.2025.104782_bib3","doi-asserted-by":"crossref","unstructured":"Feng P., Xue X., Bukhari I., Qiu C., Li Y., Zheng P., et al. Gut microbiota and its therapeutic implications in tumor microenvironment interactions. Front Microbiol [Internet]. 2024 Jan 23 [cited 2025 Apr 7];15. Available from: \u3008https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/10.3389\/fmicb.2024.1287077\/full\u3009.","DOI":"10.3389\/fmicb.2024.1287077"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/10428194.2011.621566","article-title":"Interleukin-6 plasma levels are modulated by a polymorphism in the NF-\u03baB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma","volume":"53","author":"Giachelia","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104782_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910576","article-title":"The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma","volume":"11","author":"Hashwah","year":"2019","journal-title":"EMBO Mol. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10428194.2015.1038708","article-title":"Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma","volume":"57","author":"Higashi","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ejh.12987","article-title":"An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome","volume":"100","author":"Hollander","year":"2018","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104782_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3324\/haematol.2019.243287","article-title":"Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP","volume":"106","author":"Jachimowicz","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41408-023-00927-2","article-title":"Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma","volume":"13","author":"Jain","year":"2023","journal-title":"Blood Cancer J."},{"issue":"39","key":"10.1016\/j.critrevonc.2025.104782_bib12","doi-asserted-by":"crossref","first-page":"14353","DOI":"10.1523\/JNEUROSCI.1910-15.2015","article-title":"Metabolic connection of inflammatory pain: Pivotal role of a pyruvate dehydrogenase kinase\u2013pyruvate dehydrogenase\u2013lactic acid axis","volume":"35","author":"Jha","year":"2015","journal-title":"The Journal of Neuroscience"},{"issue":"6382","key":"10.1016\/j.critrevonc.2025.104782_bib13","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PPO.0000000000000446","article-title":"Role of Microenvironment in Non-Hodgkin Lymphoma: Understanding the Composition and Biology","volume":"26","author":"Khurana","year":"2020","journal-title":"Cancer J. Sudbury Mass"},{"key":"10.1016\/j.critrevonc.2025.104782_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-8722-2-36","article-title":"Mechanism of action of lenalidomide in hematological malignancies","volume":"2","author":"Kotla","year":"2009","journal-title":"J. Hematol. OncolJ Hematol. Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104782_bib16","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3390\/cancers16193368","article-title":"The Tumor Microenvironment as a Therapeutic Target in Cutaneous T Cell Lymphoma","volume":"16","author":"Kwantwi","year":"2024","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104782_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood.2023022861","article-title":"Targeting the tumor microenvironment for treating double-refractory chronic lymphocytic leukemia","volume":"144","author":"Lewis","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104782_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/bjh.16414","article-title":"Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy","volume":"189","author":"Menter","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2025.104782_bib19","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.med.2021.05.006","article-title":"El sistema inmune y el microambiente tumoral: componentes y funci\u00f3n","volume":"13","author":"Monserrat","year":"2021","journal-title":"Med - Programa Form. M\u00e9dica Contin. Acreditado"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13046-022-02579-9","article-title":"Insights into the tumor microenvironment of B cell lymphoma","volume":"41","author":"Ng","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104782_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.637675","article-title":"The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment","volume":"9","author":"Ni","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.104782_bib22","article-title":"Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes","volume":"11","author":"Pan","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.104782_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.637186","article-title":"TH2\/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia","volume":"11","author":"Puzzolo","year":"2021","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104782_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12288-024-01770-6","article-title":"Prognostic Significance of T-Cells and Macrophages in the Tumour Microenvironment of Nodal DLBCL","volume":"40","author":"Ravi","year":"2024","journal-title":"Indian J. Hematol. Blood Transfus. J. Indian Soc. Hematol. Blood Transfus."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/14737140.2021.1853531","article-title":"High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural \/ killer T-cell lymphoma (ENKTL)","volume":"21","author":"Rong","year":"2021","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1200\/JCO.1995.13.3.575","article-title":"Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma","volume":"13","author":"Seymour","year":"1995","journal-title":"J. Clin. Oncol. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104782_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.939978","article-title":"The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia","volume":"13","author":"Sha","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104782_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.acr.2024.06.009","article-title":"Crosstalk between tumor and microenvironment: Insights from spatial transcriptomics","volume":"163","author":"Sudhakar","year":"2024","journal-title":"Adv. Cancer Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104782_bib29","article-title":"Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"S","year":"2014","journal-title":"Gastroenterol. [Internet]"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ejh.14224","article-title":"Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review","volume":"113","author":"Taghiloo","year":"2024","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104782_bib31","first-page":"92","article-title":"Microambiente tumoral: estudio, clasificaci\u00f3n y reprogramaci\u00f3n","volume":"52","author":"Una visi\u00f3n integral del c\u00e1ncer (I)","year":"2019","journal-title":"Rev. Esp. Patol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104782_bib32","first-page":"103","article-title":"B-cell chronic lymphocytic leukemia: A personalized view of the clinical and molecular aspects","volume":"15","author":"Valdespino-G\u00f3mez","year":"2014","journal-title":"Rev. Hematol."},{"key":"10.1016\/j.critrevonc.2025.104782_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/0-387-26283-0_5","article-title":"The role of immune cells in the tumor microenvironment","volume":"130","author":"Whiteside","year":"2006","journal-title":"Cancer Treat. Res"},{"key":"10.1016\/j.critrevonc.2025.104782_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106684","article-title":"Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis","volume":"85","author":"Xie","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41408-023-00899-3","article-title":"T-cell phenotype including CD57+\u2009T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma","volume":"13","author":"Yang","year":"2023","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104782_bib36","article-title":"Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities","volume":"14","author":"Y","year":"2021","journal-title":"J. Hematol. OncolJ Hematol. Oncol. [Internet]"},{"key":"10.1016\/j.critrevonc.2025.104782_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107662","article-title":"High levels of Tim-3+Foxp3+Treg cells in the tumor microenvironment is a prognostic indicator of poor survival of diffuse large B cell lymphoma patients","volume":"96","author":"Zhong","year":"2021","journal-title":"Int Immunopharmacol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T20:47:04Z","timestamp":1756154824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["S1040842825001702"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104782","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the tumor microenvironment on progression and treatment response in lymphoma and chronic lymphocytic leukemia: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104782"}}